Novartis Fights Bid To Invalidate Silicone-Free Syringe Patents
Novartis AG has hit back against two Teva subsidiaries and a Swiss pharmaceutical company's lawsuit to invalidate its patents for silicone-free syringes for eye treatments, saying there is no real basis...To view the full article, register now.
Already a subscriber? Click here to view full article